Table 2.

Most common perceived barriers among stakeholders (n = 47).

Activities focused on	Often (51–75%) n (%)	Always (>75%) n (%)
Parents & adolescents
Lack of knowledge among families that vaccine is a series of 3 shots	13 (27.7)	2 (4.3)
Lack of education/understanding about HPV and its link to cancer	18 (38.3)	3 (6.4)
Health care providers
Concerns about adding another vaccine to the vaccine schedule	6 (12.8)	0 (0.0)
Concerns about up-front cost of purchasing private stock HPV vaccine	5 (10.6)	1 (2.1)
Communities & health systems
Lack of education/understanding about HPV infection including its link to cancer	5 (10.6)	2 (4.3)
Lack of information about HPV vaccine	6 (12.8)	1 (2.1)
Lack of knowledge among families that vaccine is a series of 3 shots	6 (12.8)	1 (2.1)
Advocacy & public policy
Lack of information about HPV vaccine	3 (6.4)	1 (2.1)

^*n values represent those who indicated engaging in the relevant HPV-related activities and experienced barriers related to these activities.

^**n values differ between and within each group.